Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-013532
Filing Date
2015-02-13
Accepted
2015-02-13 16:20:29
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4321
  Complete submission text file 0001209191-15-013532.txt   5667
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139
Business Address
Silva Paul M (Reporting) CIK: 0001446372 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-19319 | Film No.: 15614909